Economic Development Innovations Singapore
Mr Abel Ang is Chief Executive Officer of EDIS. He was formerly President, Asia/Pacific for Hill-Rom Inc, an NYSE listed medical devices company (NYSE: HRC), where he was responsible for expanding Hill-Rom’s presence in the high growth Asia/Pacific markets.
He formerly served as the Chief Technology Officer for Hill-Rom for 3 years. In that role he had overall responsibility for Hill-Rom’s global R&D operations distributed across sites in the U.S., Mexico, France, and Singapore. He was also Vice-President and General Manager of Hill-Rom’s US$420M Global Surfaces and Therapy Business Unit; and Vice-President for International Business and Technology Development.
He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board’s Biomedical Division and spent 3 years in EDB’s European Operations based in Frankfurt, Germany.
In his spare time, Mr Ang teaches at the MBA programs of the Nanyang Business School in Singapore and Waseda University in Japan, which have been consistently ranked among Asia's top MBA schools. He sits on the Board of Exploit Technologies which provides access to Singapore's largest pool of intellectual property and knowledge generated by over 2,000 researchers at A*STAR's research institutes. He is also on the Supervisory Board of Dornier Medizintechnik in Germany.
Mr Ang has a Master of Science in Computational Biology from Rutgers University in New Jersey, which he pursued while on an EDB scholarship. He attended Harvard Business School’s Advanced Management Program in 2012.